The solution was centrifuged at 16,000 g for 2 min and the supernatant was used to measure absorbance at 530 nm
In the pivotal STEP-1 trial, participants taking Wegovy lost an average of 14.9% of their body weight over 68 weeks
REGULATORY NOTICE & BATCH TRACEABILITY: This product is intended strictly for in-vitro laboratory research and analytical testing
Additionally, individuals with active or recent disordered eating patterns should avoid structured fasting while on appetite-suppressing medications, as the combination can trigger harmful behavioral patterns
Our Precision Peptide Genetic Test may help provide context by revealing your predispositions in key GLP-1 and metabolic pathway variants, supporting a more personalized conversation with your provider before beginning treatment
If you're after faster results, check out our Intravenous Glutathione Infusions